Andrews Nancy C 4

What Happened Nancy C. Andrews, a director of Charles River Laboratories (CRL), reported an exempt gift/transfer on May 12, 2026. The Form 4 shows a disposition of 3,964 shares at $0.00 (gift) and a corresponding acquisition of 3,964 shares at $0.00 — reflecting an internal transfer of stock into a revocable trust she controls. No cash changed hands; the transaction is reported as $0 in value.

Key Details

• Transaction date: 2026-05-12; Form 4 filed: 2026-05-14 (appears timely).
• Transaction code: G (Gift); footnote F1: exempt transfer under Rule 16a-13 to a revocable trust controlled by the reporting person.
• Shares disposed: 3,964 @ $0.00 (gift).
• Shares acquired: 3,964 @ $0.00 (into revocable trust).
• Shares owned after transaction: Not specified in the provided filing.
• Filing accession: 0001100682-26-000073.

Context This is an administrative/estate-planning type transfer (exempt transfer to a revocable trust) rather than a market sale or purchase, so it does not indicate a cash exit or a new investment position. Gifts and transfers into trusts generally do not signal the insider’s view on the company’s stock price.